Covidien plc (COV) Tops Q2 EPS by 4c; Increases FY11 Sales Growth Outlook
Tweet Send to a Friend
Covidien plc (NYSE: COV) reported Q2 EPS of $0.93, $0.04 better than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
